Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Thermo Fisher Scientific stock in Canada | $611.96
Own Thermo Fisher Scientific shares in just a few minutes.
Thermo Fisher Scientific Inc is a diagnostics & research business based in the US. Thermo Fisher Scientific shares (TMO) are listed on the NYSE and all prices are listed in US Dollars. Thermo Fisher Scientific employs 80,000 staff and has a trailing 12-month revenue of around USD$38.3 billion.
How to buy shares in Thermo Fisher Scientific
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – TMO – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Is it a good time to buy Thermo Fisher Scientific stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
What's in this guide?
- Can I buy shares in Thermo Fisher Scientific?
- Has coronavirus impacted Thermo Fisher Scientific shares?
- Thermo Fisher Scientific shares summary
- Compare share dealing platforms
- Is Thermo Fisher Scientific stock a buy or sell?
- Thermo Fisher Scientific performance over time
- Can I short Thermo Fisher Scientific shares?
- Is Thermo Fisher Scientific suitable for ethical investing?
- Are Thermo Fisher Scientific shares over-valued?
- Thermo Fisher Scientific's financials
- How volatile are Thermo Fisher Scientific shares?
- Does Thermo Fisher Scientific pay a dividend?
- Have Thermo Fisher Scientific shares ever split?
- Other common questions
How has Coronavirus impacted Thermo Fisher Scientific's stock price?
Since the stock market crash in March caused by coronavirus, Thermo Fisher Scientific's stock price has had significant positive movement.
Its last market close was $611.96, which is 45.27% up on its pre-crash value of $334.94 and 144.58% up on the lowest point reached during the March crash when the stocks fell as low as $250.21.
If you had bought $1,000 worth of Thermo Fisher Scientific stocks at the start of February 2020, those stocks would have been worth $801.64 at the bottom of the March crash, and if you held on to them, then as of the last market close they'd be worth $1,921.55.
Thermo Fisher Scientific stock priceUse our graph to track the performance of TMO stocks over time.
Thermo Fisher Scientific shares at a glance
|Latest market close||$611.96|
|52-week range||$432.83 - $616.93|
|50-day moving average||$582.20|
|200-day moving average||$519.72|
|Wall St. target price||$653.61|
|Dividend yield||$0.96 (0.16%)|
|Earnings per share (TTM)||$21.59|
Compare online stock trading platforms
Note: The dollar amounts in the table below are in Canadian dollars.
Thermo Fisher Scientific price performance over time
|1 week (2021-10-18)||4.07%|
|1 month (2021-09-24)||0.36%|
|3 months (2021-07-23)||14.97%|
|6 months (2021-04-23)||25.38%|
|1 year (2020-10-23)||27.45%|
|2 years (2019-10-24)||108.55%|
|3 years (2018-10-24)||177.46%|
|5 years (2016-10-24)||299.69%|
Is Thermo Fisher Scientific under- or over-valued?
Valuing Thermo Fisher Scientific stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Thermo Fisher Scientific's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Thermo Fisher Scientific's P/E ratio
Thermo Fisher Scientific's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 28x. In other words, Thermo Fisher Scientific shares trade at around 28x recent earnings.
That's comparable to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29).
Thermo Fisher Scientific's PEG ratio
Thermo Fisher Scientific's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 7.5641. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Thermo Fisher Scientific's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Thermo Fisher Scientific's EBITDA
Thermo Fisher Scientific's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $13.3 billion.
The EBITDA is a measure of a Thermo Fisher Scientific's overall financial performance and is widely used to measure a its profitability.
Thermo Fisher Scientific financials
|Revenue TTM||$38.3 billion|
|Operating margin TTM||28.37%|
|Gross profit TTM||$16 billion|
|Return on assets TTM||10.49%|
|Return on equity TTM||25.76%|
|Market capitalisation||$240.8 billion|
TTM: trailing 12 months
Shorting Thermo Fisher Scientific shares
There are currently 2.6 million Thermo Fisher Scientific shares held short by investors – that's known as Thermo Fisher Scientific's "short interest". This figure is 4.1% down from 2.7 million last month.
There are a few different ways that this level of interest in shorting Thermo Fisher Scientific shares can be evaluated.
Thermo Fisher Scientific's "short interest ratio" (SIR)
Thermo Fisher Scientific's "short interest ratio" (SIR) is the quantity of Thermo Fisher Scientific shares currently shorted divided by the average quantity of Thermo Fisher Scientific shares traded daily (recently around 1.5 million). Thermo Fisher Scientific's SIR currently stands at 1.77. In other words for every 100,000 Thermo Fisher Scientific shares traded daily on the market, roughly 1770 shares are currently held short.
However Thermo Fisher Scientific's short interest can also be evaluated against the total number of Thermo Fisher Scientific shares, or, against the total number of tradable Thermo Fisher Scientific shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Thermo Fisher Scientific's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Thermo Fisher Scientific shares in existence, roughly 10 shares are currently held short) or 0.0066% of the tradable shares (for every 100,000 tradable Thermo Fisher Scientific shares, roughly 7 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Thermo Fisher Scientific.
Thermo Fisher Scientific's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Thermo Fisher Scientific.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Thermo Fisher Scientific's total ESG risk score
Total ESG risk: 14.69
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Thermo Fisher Scientific's overall score of 14.69 (as at 01/01/2019) is excellent – landing it in it in the 15th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Thermo Fisher Scientific is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Thermo Fisher Scientific's environmental score
Environmental score: 2.11/100
Thermo Fisher Scientific's environmental score of 2.11 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Thermo Fisher Scientific is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Thermo Fisher Scientific's social score
Social score: 6.69/100
Thermo Fisher Scientific's social score of 6.69 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Thermo Fisher Scientific is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Thermo Fisher Scientific's governance score
Governance score: 3.38/100
Thermo Fisher Scientific's governance score puts it squarely in the 1st percentile of companies rated in the same sector. That could suggest that Thermo Fisher Scientific is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Thermo Fisher Scientific's controversy score
Controversy score: 2/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Thermo Fisher Scientific scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that Thermo Fisher Scientific has, for the most part, managed to keep its nose clean.
Thermo Fisher Scientific share dividends
Dividend payout ratio: 3.92% of net profits
Recently Thermo Fisher Scientific has paid out, on average, around 3.92% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.17% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Thermo Fisher Scientific shareholders could enjoy a 0.17% return on their shares, in the form of dividend payments. In Thermo Fisher Scientific's case, that would currently equate to about $0.96 per share.
While Thermo Fisher Scientific's payout ratio might seem low, this can signify that Thermo Fisher Scientific is investing more in its future growth.
Thermo Fisher Scientific's most recent dividend payout was on 15 October 2021. The latest dividend was paid out to all shareholders who bought their shares by 14 September 2021 (the "ex-dividend date").
Have Thermo Fisher Scientific's shares ever split?
Thermo Fisher Scientific's shares were split on a 3:2 basis on 6 June 1996. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Thermo Fisher Scientific shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for Thermo Fisher Scientific shares which in turn could have impacted Thermo Fisher Scientific's share price.
Thermo Fisher Scientific share price volatility
Over the last 12 months, Thermo Fisher Scientific's shares have ranged in value from as little as $432.8263 up to $616.93. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Thermo Fisher Scientific's is 0.7259. This would suggest that Thermo Fisher Scientific's shares are less volatile than average (for this exchange).
Thermo Fisher Scientific overview
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs.
Stocks similar to Thermo Fisher Scientific
Frequently asked questions
Thermo Fisher Scientific in the news
THERMO FISHER SCIENTIFIC INC. : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)
STERIS (STE) Hits a New 52-Week High: What's Driving It?
The Zacks Analyst Blog Highlights: Alphabet, Netflix, Thermo Fisher Scientific, Wells Fargo and Novartis
More on investing
Stock trading doesn’t have to be expensive. Using Finder’s proprietary algorithm, we’ve identified the best cheap Canadian and US stocks to buy now.Read more…
Steps to owning and managing Cue Health stocks, with 24-hour and historical pricing before you buy.Read more…
Steps to owning and managing ARBK stock, with 24-hour and historical pricing before you buy.Read more…
More guides on Finder
How to buy AirSculpt Technologies (AIRS) stock in Canada when it goes public
Everything we know about the AirSculpt Technologies IPO, plus information on how to buy in.
How to buy Candela Medical (CDLA) stock in Canada when it goes public
Everything we know about the Candela Medical IPO, plus information on how to buy in.
How to buy Ensemble Health Partners (ENSB) stock in Canada when it goes public
Everything we know about the Ensemble Health Partners IPO, plus information on how to buy in.
How to buy Fluence Energy (FLNC) stock in Canada when it goes public
Everything we know about the Fluence Energy IPO, plus information on how to buy in.
How to buy GlobalFoundries (GFS) stock in Canada when it goes public
Everything we know about the GlobalFoundries IPO, plus information on how to buy in.
How to buy LianBio (LIAN) stock in Canada when it goes public
Everything we know about the LianBio IPO, plus information on how to buy in.
How to buy Rent the Runway (RENT) stock in Canada when it goes public
Everything we know about the Rent the Runway IPO, plus information on how to buy in.
How to buy Solo Brands (DTC) stock in Canada when it goes public
Everything we know about the Solo Brands IPO, plus information on how to buy in.
How to buy Udemy (UDMY) stock in Canada when it goes public
Everything we know about the Udemy IPO, plus information on how to buy in.
How to buy Arteris (AIP) stock in Canada when it goes public
Everything we know about the Arteris IPO, plus information on how to buy in.
Ask an Expert
You must be logged in to post a comment.